Raaj Medisafe India Ltd.
Snapshot View

17.50 ▼0%

12 July 2021, 04:00:00 P.M.

Overview View Details

Sector Healthcare Compare with Sector peers
Industry Medical Equipment/Supplies/Accessories Compare with Industry peers
Website http://www.raajmedisafeindia.com
Financial Indicators
Market Cap 8.82 Cr.
Earnings per share (EPS) 4.56 Trailing Twelve Months Ending 2021-03
Price-Earning Ratio (PE) 3.84 Trailing Twelve Months Ending 2021-03
Industry PE - Trailing Twelve Months Ending 2021-03
Book Value / Share -18.63 Trailing Twelve Months Ending 2021-03
Price to Book Value -0.94 Calculated using Price: 17.50
Dividend Yield 0.00 Period Ending 2020-03
No. of Shares Subscribed 0.50 Cr. 5,040,000 Shares
FaceValue 10
Company Profile

Raaj Medisafe India is a venture of packaging people group. The group is dealing with the heads of pharma & hygiene sector since 20 years with many topmost brands across the globe. The company’s impressive industry spreads in 27,000 sqm. area at Pithampur Industrial Area in Madhya Pradesh. Its moto is to produce best quality products to give 100% hygienic and infection free products in Hospitals, Nursing Homes, Spas etc. Its product range is produced with world class technologies and on fully automatic machines. There is no human touch on product, and entire process is carried out in clean room environment.

Business area of the company

The company deals in wide range of personal and hospital hygiene related products like disposable bed sheets, pillow covers, stretcher sheets, under pads, sanitary napkins, panty liners, baby diapers & adult diapers, etc.

Products:

  • Medisafe Underpads
  • Medisafe Stretcher Sheet
  • Medisafe Disposable Pilow Cover
  • Medisafe Disposable Bed Sheet
  • Surgical Gowns
  • Reinforced Surgical Gowns
  • Wrap Around Surgical Gowns
  • Patient Gowns
  • Surgical Drapes of different sizes
  • SMS Mask
  • Ear Loop Mask
  • Tie on Mask
  • Bouffant Cap
  • Surgeon Cap
  • Shoe Cover
  • Sanitary Napkin
  • Panty Liners
  • Panty Liners
  • Adult Diapers

Delivery View Details

Delivered Qty
Traded Qty

Performance View Details

1 Day
1 Week
1 Month
+4.79%
3 Month
+14.98%
6 Month
+55.56%
1 Year
+35.76%
2 Year
+68.76%
5 Year
+122.08%
9 years 2012-03 2013-03 2014-03 2015-03 2016-03 2017-03 2018-03 2019-03 2020-03
Return on Equity (%) -535.15
Return on Capital Employed (%) -71.37 -23.69 -20.12 -24.25 -13.98 -8.33 -21.00 -24.82 -10.18
Return on Assets (%) -69.72 -23.11 -21.30 -33.33 -22.40 -15.08 -26.04 -30.95 -24.16

Balance Sheet View Details

Particulars 9 years 2012-03 Rs. Cr. 2013-03 Rs. Cr. 2014-03 Rs. Cr. 2015-03 Rs. Cr. 2016-03 Rs. Cr. 2017-03 Rs. Cr. 2018-03 Rs. Cr. 2019-03 Rs. Cr. 2020-03 Rs. Cr.
Shh. Funds -1 -1 -1 -3 -4 -5 -6 -8 -9
Non Curr. Liab. 2 3 4 7 7 8 8 10 11
Curr. Liab. 0 0 0 0 2 3 3 3 4
Minority Int.
Equity & Liab. 2 2 3 4 5 6 5 5 6
Non Curr. Assets 2 1 2 3 4 4 3 3 3
Curr. Assets 0 0 1 1 2 2 2 2 3
Misc. Exp. not W/O
Total Assets 2 2 3 4 5 6 5 5 6

Profit Loss View Details

Particulars 9 years 2012-03 Rs. Cr. 2013-03 Rs. Cr. 2014-03 Rs. Cr. 2015-03 Rs. Cr. 2016-03 Rs. Cr. 2017-03 Rs. Cr. 2018-03 Rs. Cr. 2019-03 Rs. Cr. 2020-03 Rs. Cr.
Net Sales 0 2 4 4 5 5
Other Income 0 0 0 0 0 0
Total Income 0 0 0 2 4 4 5 6
Total Expenditure -2 0 0 -1 -2 -4 -4 -6 -6
PBIDT -2 0 0 -1 0 0 0 -1 0
Interest 0 0 0 0 -1 -1 -1 -1 -1
Depreciation 0 0 0 0 0 0 0 0 0
Taxation
Exceptional Items 0 0 0 0 0 0
PAT -2 0 0 -1 -1 -1 -1 -2 -1

Cash Flow View Details

Particulars 9 years 2012-03 Rs. Cr. 2013-03 Rs. Cr. 2014-03 Rs. Cr. 2015-03 Rs. Cr. 2016-03 Rs. Cr. 2017-03 Rs. Cr. 2018-03 Rs. Cr. 2019-03 Rs. Cr. 2020-03 Rs. Cr.
Cash Fr. Operatn. 0 0 -1 0 0 0 0 -1 -1
Cash Fr. Inv. 0 0 -2 -1 -1 0 0 0
Cash Fr. Finan. 0 0 1 3 0 1 0 1 1
Net Change 0 0 0 0 0 0
Cash & Cash Eqvt 0 0 0 0 0 0 0 0 0

Shareholding Pattern View Details

9 Qtrs 2019-03 (%) 2019-06 (%) 2019-09 (%) 2019-12 (%) 2020-03 (%) 2020-06 (%) 2020-09 (%) 2020-12 (%) 2021-03 (%)
Promoter 44.85 44.85 44.85 44.85 44.85 44.85 44.85 44.85 44.85
Public 55.15 55.15 55.15 55.15 55.15 55.15 55.15 55.15 55.15
Depository Receipts 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Promoter Holding Pledge (%) 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00

Announcements View Details

Mon, 19 Jul 2021
Related Party Transactions For The Half Year Ended March 31 2021
Disclosure of Related Party transactions pursuant to Regulation 23 (9) of the SEBI (Listing Obligation and Disclosure Requirements) Regulations 2015
--------------------------------------------------------------------------------------------------------------

pursuant to Regulation 23 (9) of the SEBI (Listing Obligation and Disclosure Requirements) Regulations 2015 we enclose herewith the statement regarding disclosure of related party transactions on consolidated basis in the format specified in the Accounting Standards for the half year ended March 31 2021.
Sat, 17 Jul 2021
Shareholding for the Period Ended June 30 2021
Raaj Medisafe India Ltd has submitted to BSE the Shareholding Pattern for the Period Ended June 30 2021. For more details kindly Click here
Thu, 15 Jul 2021
Revised Audited Financial Results For The Quarter/Year Ended March 31 2021
Revised Financial results of the Company for the quarter/year ended March 31 2021 duly rectified the discrepancy.

Technical Scans View Details

No Scans Found

Related Stocks View Details

Stock Name Market Cap(Rs. Cr.) LTP Chg %
Sun Pharmaceutical Industries Ltd. 166,513.85 694.00 +1.0%
Divi's Laboratories Ltd. 128,088.59 4,825.00 -0.4%
Dr. Reddy's Laboratories Ltd. 90,175.51 5,420.50 +0.7%
Cipla Ltd. 76,510.04 948.50 -0.1%
Cadila Healthcare Ltd. 62,965.29 615.05 -0.9%
Aurobindo Pharma Ltd. 56,484.48 964.00 -0.8%
Apollo Hospitals Enterprise Ltd. 56,291.69 3,915.00 -1.8%
Stock Name Statement TTM Ending Price Earning Ratio(TTM) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2021-03 57.34 694.00 +1.0%
Divi's Laboratories Ltd. Consolidated 2021-03 64.55 4,825.00 -0.4%
Dr. Reddy's Laboratories Ltd. Consolidated 2021-03 46.21 5,420.50 +0.7%
Cipla Ltd. Consolidated 2021-03 31.81 948.50 -0.1%
Cadila Healthcare Ltd. Consolidated 2021-03 29.51 615.05 -0.9%
Aurobindo Pharma Ltd. Consolidated 2021-03 10.59 964.00 -0.8%
Apollo Hospitals Enterprise Ltd. Consolidated 2021-03 374.38 3,915.00 -1.8%
Stock Name Statement TTM Ending Price To Book Value(TTM) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2021-03 3.58 694.00 +1.0%
Divi's Laboratories Ltd. Consolidated 2021-03 13.78 4,825.00 -0.4%
Dr. Reddy's Laboratories Ltd. Consolidated 2021-03 5.15 5,420.50 +0.7%
Cipla Ltd. Consolidated 2021-03 4.17 948.50 -0.1%
Cadila Healthcare Ltd. Consolidated 2021-03 4.85 615.05 -0.9%
Aurobindo Pharma Ltd. Consolidated 2021-03 2.58 964.00 -0.8%
Apollo Hospitals Enterprise Ltd. Consolidated 2021-03 12.25 3,915.00 -1.8%
Stock Name Statement Year Ending Debt Equity Ratio LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2020-03 0.18 694.00 +1.0%
Divi's Laboratories Ltd. Consolidated 2020-03 0.00 4,825.00 -0.4%
Dr. Reddy's Laboratories Ltd. Consolidated 2021-03 0.17 5,420.50 +0.7%
Cipla Ltd. Consolidated 2020-03 0.18 948.50 -0.1%
Cadila Healthcare Ltd. Consolidated 2021-03 0.35 615.05 -0.9%
Aurobindo Pharma Ltd. Consolidated 2020-03 0.33 964.00 -0.8%
Apollo Hospitals Enterprise Ltd. Consolidated 2020-03 1.08 3,915.00 -1.8%
Stock Name Statement Year Ending Return On Equity(%) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2020-03 9.66 694.00 +1.0%
Divi's Laboratories Ltd. Consolidated 2020-03 19.30 4,825.00 -0.4%
Dr. Reddy's Laboratories Ltd. Consolidated 2021-03 11.53 5,420.50 +0.7%
Cipla Ltd. Consolidated 2020-03 10.09 948.50 -0.1%
Cadila Healthcare Ltd. Consolidated 2021-03 18.30 615.05 -0.9%
Aurobindo Pharma Ltd. Consolidated 2020-03 18.53 964.00 -0.8%
Apollo Hospitals Enterprise Ltd. Consolidated 2020-03 13.08 3,915.00 -1.8%
Stock Name Statement Year Ending Return On Capital Employed(%) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2020-03 10.07 694.00 +1.0%
Divi's Laboratories Ltd. Consolidated 2020-03 25.36 4,825.00 -0.4%
Dr. Reddy's Laboratories Ltd. Consolidated 2021-03 15.24 5,420.50 +0.7%
Cipla Ltd. Consolidated 2020-03 12.53 948.50 -0.1%
Cadila Healthcare Ltd. Consolidated 2021-03 13.65 615.05 -0.9%
Aurobindo Pharma Ltd. Consolidated 2020-03 18.80 964.00 -0.8%
Apollo Hospitals Enterprise Ltd. Consolidated 2020-03 17.13 3,915.00 -1.8%
Stock Name Statement Year Ending Net Sales(Rs. Cr.) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2020-03 32,837.50 694.00 +1.0%
Divi's Laboratories Ltd. Consolidated 2020-03 5,394.42 4,825.00 -0.4%
Dr. Reddy's Laboratories Ltd. Consolidated 2021-03 19,047.50 5,420.50 +0.7%
Cipla Ltd. Consolidated 2020-03 17,131.99 948.50 -0.1%
Cadila Healthcare Ltd. Consolidated 2021-03 15,102.20 615.05 -0.9%
Aurobindo Pharma Ltd. Consolidated 2020-03 23,098.51 964.00 -0.8%
Apollo Hospitals Enterprise Ltd. Consolidated 2020-03 11,246.80 3,915.00 -1.8%
Stock Name Statement Year Ending Profit After Tax(Rs. Cr.) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2020-03 4,186.79 694.00 +1.0%
Divi's Laboratories Ltd. Consolidated 2020-03 1,376.54 4,825.00 -0.4%
Dr. Reddy's Laboratories Ltd. Consolidated 2021-03 1,903.60 5,420.50 +0.7%
Cipla Ltd. Consolidated 2020-03 1,546.98 948.50 -0.1%
Cadila Healthcare Ltd. Consolidated 2021-03 2,137.60 615.05 -0.9%
Aurobindo Pharma Ltd. Consolidated 2020-03 2,844.69 964.00 -0.8%
Apollo Hospitals Enterprise Ltd. Consolidated 2020-03 434.90 3,915.00 -1.8%